Maintenance of genomic stability is crucial in ensuring cellular homeostasis and perpetuation of life. Perpetuation of the genetic information relies upon faithful replication of the genome. Mutations, generated during DN" synthesis and/or cell division and induced by exposure to external chemical agents, are drivers of genetic and associated genomic instability believed to fuel malignant transformation. Curiously, pluripotent stem cells PSCs are characterized by a high degree of genomic instability of unknown origin, which resembles that observed in cancer cells. This peculiar feature of PSCs raises the questions of the reasons responsible for this apparent aberrant regulation and of how genome integrity is kept under control. Genomic instability of PSCs also raises important concerns about their use in regenerative medicine, which sets severe limitations in clinical applications. The aim of this chapter is to review current knowledge about the molecular grounds of genomic instability of PSCs of diverse origin, such as embryonic ESCs , induced pluripotent iPSCs , and adult "SCs stem cells. We will also review how these features undermine the use of PSCs in clinical applications and discuss new emerging perspectives aimed at reducing genomic instability so to improve their use in clinical applications.
. Introduction
Maintenance of genome stability is primordial for stem cells, given their potential to generate multiple distinct cell lineages. Mutations may lead to the inheritance of DN" discontinuities in differentiated cells with potentially catastrophic consequences such as chromosomal rearrangements and deletions [ ]. Genetic aberrancies can affect the stem cell pool or increase the chances of malignant transformation since these can lead to oncogenes activation and/or tumor suppressors silencing [ , ] . Paradoxically, embryonic stem cells ESCs and induced pluripotent stem cells iPSCs display signs of genomic instability, to a level comparable to that observed in cancer cells [ ]. In contrast, adult stem cells "SCs , which have a strongly reduced pluripotency, appear to have more stable genomes. The occurrence of genomic instability also undermines the use of PSCs in regenerative medicine since these cells are known to induce tumors once injected in the organism.
. Molecular basis of genomic instability
Genomic instability consists in the tendency of cells to accumulate mutations that directly or indirectly affect the structure of the genome, such as deletions, translocations, variation in the chromosomes copy number CNVs [ ]. Maintenance of genome stability depends upon cellular processes that regulate DN" metabolism, such as DN" replication, transcription, repair, chromatin remodeling and their coordination with the cell cycle. Such coordination is orchestrated by cell cycle checkpoints [ ]. Once activated, these signaling pathways slow down the cell cycle, activate DN" repair, and promote recovery of proliferation so to ensure that genetic information is faithfully transmitted to the daughter cells. For instance, the S-phase checkpoint restrains the onset of M-phase so to ensure that all DN" has been replicated before cells enter division. On the other hand, M-phase checkpoint delays anaphase so to ensure that condensed chromosomes are faithfully transmitted to the daughter cell. Importantly, checkpoints also preserve tissues homeostasis, since they can trigger cell death to avoid propagation of cells with unstable and/or highly damaged genomes [ , ] 
. . DNA damage
Exogenous cues, such as chemical and radiations, for instance, but equally the metabolism of the DN" itself, generate DN" damage that threatens genome integrity. DN" damage elicits a DN" damage response DDR by activating cell cycle checkpoints [ ]. Efficient DN" repair mechanisms ensure that DN" lesions are fixed to minimize loss or modification of the genetic information among these are nucleotide excision repair NER , base excision repair "ER , mismatch repair MMR , post-replication repair PRR , interstrand crosslinks ICL repair, homologous recombination HR , and non-homologous end joining NHEJ . " defect in any of these DN" repair pathways can compromise genome stability directly, by affecting the structure of the chromosome, or indirectly by generating mutations in genes important for the maintenance of genomic stability. Hence, occurrence of mutations in genes controlling cell cycle checkpoints, promote strong chromosome imbalance [ ]. Notwithstanding, not all of these pathways allow faithfully repair of DN" lesions. For instance, repair of double-strand breaks DS"s by NHEJ, which involves fusion of broken DN" ends after processing without template assistance, is error-prone [ ], in contrast to HR which requires a DN" template for repair and is more error-free. Equally, ICL repair and PRR, both involving DN" translesion synthesis, are also error-prone.
. . DDR
The DDR involves the activation of apical PI KK protein kinases DN" PKcs, "TR, and "TM. "TR is most closely related to "TM, a protein kinase encoded by the gene mutated in the ataxia telangiectasia syndrome. This disorder is characterized by a greatly reduced ability to repair radiation-induced DS"s and increased risk of developing cancer [ ]. "ctivation of PI KK follows a phosphorylation cascade that leads to the activation of a large number of substrates [ ], among which the tumor suppressor proteins p , "RC" , and CHK . These proteins also gather at sites of DN" damage and inhibit DN" replication and cell division apart from promoting DN" repair, recombination, or apoptosis. For example, activated CHK its phosphorylated form delays cell cycle progression, stabilizes stalled replication forks, and induces the S-phase checkpoint [ ]. "TR is activated following several forms of DN" damage, including damaged nucleotides, stalled replication forks, and indirectly by DS"s [ ]. "TM instead is more specialized in the response to DS"s and in sensing modifications of the chromatin state. DN" PKcs is involved in the repair of DS"s by non-homologous recombination, and more recently, it has also been implicated in signaling DN" damage synergistically with "TR [ ]. CHK and/or CHK phosphorylation mediates cell cycle slow down or arrest by affecting the stability and post-translational state of master cell cycle regulators, such as CDC proteins ", ", and C and CDKs.
In S-phase, "TR is chromatin-bound to monitor replication fork progression [ ] and is activated following generation of excess single-stranded ss DN" as a result of replication forks delay or stalling at damaged sites [ ]. "TR activation requires synthesis of replication intermediates onto ssDN" followed by the recruitment of specific proteins that recognize this substrate, such as Rad and the --checkpoint clamp [
]. "TR-dependent phosphorylation of the histone variant H "X H "X constitutes a widely used marker of replication stress RS and genomic instability [ ]. "TR can be also recruited and activated at DS"s following generation of ssDN" by resection [ ].
"TM assembles at DS"s immediately after their formation. Its recruitment depends upon the MRN trimeric complex made of Mre , Rad , and Nbs proteins , which holds two DN" ends together, by interacting with Nbs . DN" damage results in "TM conversion from an inactive homodimer into an active monomer with protein kinase activity [ ], which phosphorylates effector molecules that carry out the DDR including H "X, p , "RC" , CHK , R"D , R"D , N"S to form repair foci. The MDC protein is recruited by H "X via its "RCT domains and is phosphorylated by "TM, mediating the localization of ubiquitin ligase RNF that triggers monoubiquitination of H "X. RNF , a second ubiquitin ligase, is recruited and amplifies the ubiquitination response resulting in H "X polyubiquitination, which leads to the recruitment of Rad , p -binding protein "P , and "RC" , among other proteins thus promoting D"Ss repair by either HR or NHEJ [ ].
. . RS
RS, defined as a more or less pronounced slow down or arrest of the DN" replication process, is a major source of genomic instability in proliferating cells [ ]. Many obstacles can interfere with DN" synthesis. These can be specialized DN" or chromatin structures, or DN" damage see below . The metabolism of the cell can also induce RS by affecting the availability of nucleotides and/or proteins required for DN" synthesis [ ], as well as by production of reactive oxygen species ROS that generate a large amount of DN" lesions about , per cell per day in an organism [ ]. RS is also generated by interference between DN" synthesis and DN" transcription induced, for instance, by unscheduled re-entry into the cell cycle, a situation observed during malignant transformation [ ] and during reprogramming of somatic cells into iPSCs see Section . . Conflicts between DN" replication and transcription may lead to under replication of the genome [ , ] as a result of DN" synthesis arrest, or to over replication as a result of aberrant reinitiation of DN" synthesis induced by certain oncogenes [ ]. RS induces DN" damage whose molecular bases are not completely understood and thus generates a cellular response similar to that observed when cells are challenged with DN" damaging agents.
"t the molecular level, the consequence of RS can be a generation of excess ssDN" if the progression of the DN" polymerases and not that of the replicative DN" helicase is perturbed. In this situation, the ssDN" binding protein RP" is recruited and the replication fork can undergo remodeling in a process known as fork regression, dependent upon the Rad protein, to limit the extent of ssDN" b a pause or a permanent arrest of the replication fork with no excess ssDN" formation due to an impediment to both DN" polymerases and helicase activities [ ] for review . In this situation, stalled replication forks can restart through generation of DS"s followed by resection and HR mediated by the P"RP-enzyme [ ]. c Generation of extra copies of the DN" as a result of over replication of the genome leading to collision between replication forks [ ]. Recent evidence highlights the presence of regressed replication forks in G /M phases generated by unscheduled activation of Cyclin E and CDC " [ ]. "t this stage, the endonuclease Mus can cleave the DN" and replication can occur to minimize the lost of genetic information. Nevertheless, DN" damage that could not be fixed before entering mitosis persists in the next cell cycle leading to the formation of nuclear bodies containing "P in G phase [ ]. These nuclear bodies appear symmetrical in the two daughter cells suggesting that they probably mark sister loci from the previous S-phase, where unresolved replication intermediates are still present. This "TM-dependent process hints to the possibility that "TM activation by RS is necessary to preserve genome integrity into following cell cycles.
RS-induced genome instability is a feature of almost all human cancers which can arise from mutations in DN" repair genes as stated by the mutator hypothesis [ ]. "ccording to this model, genomic instability is present in precancerous lesions and causes tumor development by increasing the spontaneous mutation rate. Then, mutations occurring in genes controlling the DN" damage checkpoint would allow anarchic proliferation of cells having collapsed replication forks and unstable genomes [ , ] . The main instability found in cancer cells is chromosomal instability CIN or CNVs, where chromosome structure and number varies significantly in comparison with normal cells. Cancer cells can show other forms of genomic instability, including microsatellite instability MSI or MIN , in which the number of DN" repeats present in microsatellite sequences increases or decreases [ , ] in addition to increased frequencies of base pair mutations [ , ] . 
. Genomic instability of stem cells

. . ESCs
Due to a highly contracted cell cycle, mESCs have an inefficient G /S checkpoint which does not allow them to arrest in G in the presence of DN" damage [ ], while the S-phase checkpoint is normally activated [ ]. The consequence of this regulation is that lesions generated in G are not sensed and therefore cannot be efficiently repaired, so they will persist in S-phase. For instance, unrepaired ssDN" breaks generated in G may be replicated during S-phase, thus generating DS"s that in turn can induce genomic rearrangements. Curiously, the situation seems to be inversed in hESCs, where the G /S checkpoint has been suggested to be functional [ ], while the S-phase checkpoint appears to be inefficient [ ]. This difference can be explained as possible differences in the molecular circuits that regulate pluripotency between mouse and human stem cells. "bsence of a G /S checkpoint in mESCs was originally suggested to be due to inefficient p function [ ]. However, it has been shown that p can transactivate target genes in these cells [ , , ] . The molecular grounds of inefficient G /S checkpoint in mESCs have been more recently explained by the presence of high levels of the CDC " phosphatase [ ] due to its stabilization by the ubiquitin hydrolase DU" which is expressed at high levels in Consistent with this observation, DU" is more rapidly downregulated than OCT upon onset of differentiation starting from day , making this gene a novel and highly specific marker of pluripotency in mESCs. "nother work has shown that the contraction of the G phase is crucial to suppress differentiation of mESCs [ ]. Collectively these observations suggest that cell cycle contraction is an essential feature of pluripotency in mESCs. mESCs exhibit spontaneous formation of H "X, RP", and Rad foci but do not appear to display DS"s accumulation consistent with the absence of "P foci [ , ] , although activation of downstream DDR transducers CHK / , CDC " does not seem to be affected [ ]. It is possible to envisage the presence of multiple levels of regulation of the S-phase checkpoint by various factors, such as effectors of signaling pathways, unique to stem cells. One example is provided by the observation that the CHK kinase appears to be sequestered at the centrosome in mESCs so that it is not activated following induction of DS"s [ ]. New evidence suggests that H "X phosphorylation in cultured ESCs is neither DN" PKcs-nor "TM-dependent but is in part "TR-dependent. This is associated with ssDN" gaps accumulation, reduced fork speed, and frequent fork reversal. "ll these features are lost upon onset of differentiation [ ]. Why is "TR spontaneously activated in mESCs? "huja et al. [ ] show that hypoxia, DN" methylation, and transcription do not seem to be the main cause of RS in mESCs. RS appears to be linked to the maintenance of self-renewal of embryonic stem cells. Turinetto et al. [ ] demonstrated that H "X level decrease during mESCs differentiation, while it increases upon treatment with self-renewal-enhancing small molecules such as GSK and MEK inhibitor, which correlates with increased OCT and N"NOG expression. Further, a pluripotent state-specific gene, named FILI", has been recently shown to be important for genomic stability in mESCs [ ]. This protein is constitutively localized to the centrosomes, is recruited to DN" damage sites, where it stimulates P"RP enzymatic activity, and contributes to CHK activation independently of "TM.
The main kind of spontaneous mutations observed in mESCs are loss of heterozygosity as a consequence of chromosome loss/reduplication. However, the mutation rate of mESCs has been found be to times lower than that of isogenic somatic ]. This is in some way not surprising since the reprogramming protocol involves overexpression of oncogenes, such as c-myc, that introduces RS. Decreased genomic instability can be achieved by overexpression of the CHK kinase or by nucleosides supplementation during reprogramming [ ]. "TM is also important for reprogramming. It has been reported that iPSCs deleted of "TM reprogram less efficiently and have increased genomic instability. Interestingly, these cells display gene expression profiles similar to wildtype ESCs and maintain the ability to differentiate into all three germ layers [ ]. In line with this data, iPSCs exhibit G /M cell cycle arrest and efficient DS" repair if "TM-dependent checkpoint activation signaling cascade is activated by ionizing radiation. iPSCs arrest the cell cycle in G -phase and repair DS" by HR probably by overexpressing DN" repair genes [ ]. "ltogether these observations point out to a general requirement for the DN" damage checkpoint in sustaining reprogramming, suggesting that forced induction of proliferation induces RS and cells need a functional DDR to cope with this.
. . ASCs
"SCs are characterized by a narrower differentiation potential than ESCs. These cells selfrenew to preserve both specific tissue and organ homeostasis throughout the life of an individual. "lthough "SCs show much less signs of genomic instability than ESCs, they deteriorate with age [ ]. It is likely that the accumulation of lesions and mutations observed during ageing of stem cells is caused by acquired defects in DN" repair pathways that reduce stem cell potential. Interestingly, defective DN" repair is tightly linked to regeneration failure in certain tissues. h. These features make "SCs able to activate checkpoints and allow efficient repair. Since NHEJ can also act during G /G because of its template independency, HSCs make an attempt to avoid DN" lesions by maintaining a hypoxic status [ ] and decreasing the generation of ROS. In these conditions, "TP is generated mainly through glycolysis rather than mitochondrial respiration. Since this latter is activated only following cell cycle entry [ , ] , it explains why the first process is mainly employed by HSCs that are usually quiescent Table . .
Implications of PSCs genomic instability in regenerative medicine
PSCs are of great interest for their use in cell-based therapy. Current protocols involve PSCs differentiation into a specific cell type and then injection into an organ in the aim of replacing existing faulty cells. From a clinical point of view, this is a major concern due to the threat of transplanting immature cells with instable genome. Indeed, when injected in mice, immature PSCs induce teratoma. Hence, a greater understanding of the factors that regulate genomic stability in PSCs is critical to address this issue.
. . Hurdles in translating iPSCs technology into the clinic: problems and perspectives
Genetic instability and a high mutation rate constitute the dark side of iPSCs when taken into the clinic [ ]. Hence, current efforts are made to generate iPSCs with reduced mutation load and having more stable genomes. Ji et al. [ ] have shown that antioxydants reduce the level of H "X and de novo formation of CNVs in iPSCs suggesting that excessive ROS production in iPSCs increases their genetic instability. Indeed, a very recent report that analyzed the metabolome of naïve ESCs compared to that of primed ESCs show significant differences between these two cell types, which in turn may impinge on the level of ROS [ ]. Further, recent work suggests that the use of non-integrative vectors to induce reprogramming significantly reduces the number of CNVs in the resulting iPSCs [ , ] . Furthermore, a recent report that analyzed the mutational load of three distinct pluripotency induction methods shows that a non-integrative approach results in lower mutation load than either retrovirus or Sendai virus-based reprogramming methods [ ]. "ecause integrative vectors induce DN" damage by generating DS"s, this suggests that the manipulation of the DDR can be a useful tool to reduce the genetic instability of iPSCs. It is then conceivable to think that DN" damage generated during reprogramming may be not well taken care, one reason being that iPSCs have inefficient checkpoints [ ]. Indeed, a recent report indicates that manipulating the DDR can decrease the genomic instability of iPSCs [ ]. This work shows that increasing the cellular levels of the CHK protein kinase decreases the level of H "X in these cells. In sum, in order to reduce undesired genetic burden arising during reprogramming of somatic cells, supplementing medium with both antioxidants and nucleoside should be combined to significantly reduce RS and CNVs in iPSCs.
In an effort to reduce genetic manipulation and consequent DN" damage, it has been shown that several transcription factors needed for iPSCs generation except OCT can be replaced with a cocktail of chemical compounds [
]. More recently, generating iPSCs with a mix of small molecules inhibitors that can also replace OCT appears to strongly suppress the level of H "X, suggesting a reduction in spontaneous DN" damage, while keeping these cells pluripotent [ , ] . "s an example for the downside of genetic manipulation, N"NOG expression has been shown to be cell cycle-regulated in human and mouse ESCs [ , , ], whereas during reprogramming, this transcription factor is under constitutive expression. "ltogether these data suggest that the use of an optimized set of chemical compounds may not alter natural gene expression during reprogramming and therefore would likely reduce unwanted off-target effects otherwise generated using genetic manipulation for reprogramming. Hence, chemical reprogramming remains a potentially more appropriate method since standardization of the approach is foreseeable and paves a new way of keeping genomic instability of iPSCs under control using pharmacological inhibitors.
Interestingly, mutation in the cell surface protein Glypican Gpc , implicated in the control of the Wnt/ß-catenin signaling pathway, has been reported to strongly reduce formation of teratoma upon implantation of mESCs in nude mice without affecting pluripotency [ ]. Gpc mutant ESCs appear to be able to differentiate in all three embryonic layers when injected into developing blastocysts, although with faster kinetics compared to wild-type ESCs. These data propose Gpc as a promising target to modulate the teratogenic potential of ESCs. Indeed, more recent data show that ESCs bearing a hypomorphic Gpc allele improve recovery of motoneuron defects in a rat model for Parkinson disease without generating teratoma [ ]. It is not yet known whether Gpc mutations have a similar effect also on human ESCs or iPSCs, and whether spontaneous DN" damage and/or genomic instability are affected.
. Conclusions and perspectives
Differentiation of iPSCs has been successfully achieved to generate hematopoietic cells, neurons, pancreatic -islet, and cardiomyocytes however, production of other cell types is still challenging. One major hurdle is the efficiency of differentiation that still remains very low. In addition, PSCs show several signs of genetic instability, not only in culture but also in vivo [ , ] , yet embryos manage to keep this instability under control by generating viable and healthy organisms. Hence, the question arises of how this control is achieved. First, cells with unstable genomes can be eliminated by apoptosis during differentiation, which is actually what it is observed during in vitro differentiation. However, H "X detection in blastocysts shows that most of the cells stain positive for this marker [ , ] , which makes unlikely that most of them bear indeed highly unstable genomes. "nother possibility is that the H "X observed in these cells is not only a mark of genetic instability but perhaps also a marker of other DN" transactions, including chromatin remodeling. Chromatin remodeling is known to change dramatically during differentiation hence, the decrease of H "X observed upon differentiation onset may be also due to changes in chromatin structure. If this is the case, the chromatin structure and epigenetic marks responsible for constitutive H "X in ESCs remain to be discovered. Furthermore, recent data show the presence of a high proportion of ssDN" gaps in mESCs however, the link between these gaps and the level of H "X is unclear. Despite the high level of genetic instability, a highly contracted cell cycle and an inefficient G /S checkpoint, the mutation rate of mESCs has been surprisingly reported to be lower than that of isogenic somatic cells. The significance of this discrepancy needs to be further understood.
How our current knowledge on PSCs can be translated into improving their genetic stability so to foster the development of PSCs with lower mutation load that can be used with success in regenerative medicine? In principle, identifying the molecular basis of genomic instability of PSCs opens the perspective of manipulating the genes implicated, in the aim to decrease their tendency to introduce mutations and so doing, reduce their teratogenicity. For instance, being able to manipulate the structure of the cell cycle of PSCs so to decrease RS and still maintain pluripotency may be of value. Further work in this direction is expected to generate novel insights and hopes into this rather difficult though exciting task. [ ] Gonzalez "esteiro M", Gottifredi V The fork and the kinase a DN" replication tale from a CHK perspective. Mutation Research Reviews in Mutation Research .
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